Nov 02, 2022
New York [US], November 2: U.S. pharmaceutical and biotechnology corporation Pfizer Inc. on Tuesday reported expectation-beating results for the third quarter of 2022 driven by strong sales growth of oral antiviral treatment Paxlovid and COVID-19 vaccine booster Comirnaty in the United States.
Read More...
Nov 02, 2022
Nov 02, 2022
Nov 02, 2022
Nov 02, 2022
Tokyo [Japan], November 2: Japanese authorities reported Tuesday an outbreak of highly pathogenic bird flu at a...
Nov 02, 2022
Hanoi [Vietnam], November 2: Although Vietnamese manufacturing sector's business conditions continued to improve in October, there were...
Nov 02, 2022
Yangon [Myanmar], November 2: Myanmar extended its COVID-19 preventive measures until Nov. 30, the Central Committee on...
Nov 02, 2022
Nov 02, 2022
Nov 01, 2022
Nov 01, 2022
Nov 01, 2022
Nov 01, 2022
